Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy

Laryngoscope

Volumn 116, Issue 12, 2006, Pages 2108-2112

  Jeyakumar, Anita ^a   Brickman, Todd M ^b   Haben, Michael ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Amitriptyline; Chronic cough; Cough suppressants; Postvagal viral neuropathy

Indexed keywords

AMITRIPTYLINE; CODEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUAIFENESIN; PROTON PUMP INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; MALE; NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VAGUS NERVE;

AMITRIPTYLINE; ANTITUSSIVE AGENTS; CHRONIC DISEASE; CODEINE; COUGH; DRUG COMBINATIONS; EXPECTORANTS; FEMALE; GUAIFENESIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; VAGUS NERVE DISEASES;

EID: 33845509290     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000244377.60334.e3     Document Type: Article

References (15)

1. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med 1998;158:1657-1661.
2. Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 2004;114:253-257.
3. Al-Mobeireek AF, Al-Sarhani A, Al-Amri S, Bamgboye E, Ahmed S. Chronic cough at a non-teaching hospital: are extrapulmonary causes overlooked? Respirology 2002;7:141-146.
4. McGarvey LPA, Ing AJ. Idiopathic cough, prevalence and underlying mechanisms. Pulm Pharmacol Ther 2004;17:435-439.
5. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality of-life questionnaire. Chest 2002;121:1123-1131.
6. Farrer J, Keenan J, Levy P. Understanding the pathology and treatment of virus-induced cough. Home Healthcare Consult 2001;10-18.
7. Irwin R, Boulet L, Cloutier M, et al. Managing cough as a defense mechanism and as a symptom: a consensus report of the American College of Chest Physicians. Chest 1998;133-181.
8. Amin MR, Koufman JA. Vagal neuropathy after upper respiratory infection: a viral etiology? Am J Otolaryngol 2001;22:251-256.
9. Lin L, Poh KL, Lim TK. Empirical treatment of chronic cough: a cost-effectiveness analysis. Proc AMIA Symp 2001;383-387.
10. O'Connell F, Thomas VE, Pride NB, Fuller RW. Cough sensitivity to inhaled capsaicin decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 1993;150:374-380.
11. McGarvey LPA, Heaney LG, Lawson JT, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998;53:738-743.
12. Irwin RS, Madison JM. Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med 2000;108:126S-130S.
13. Morice AH, Fontana GA, Sovijarvi ARA, et al. The diagnosis and management of cough. Eur Respir J 2004;24:481-492.
14. Carr MJ. Plasticity of vagal afferent fibres mediating cough. Pulm Pharmacol Ther 2004;17:447-451.
15. Marchesani F, Cecarini L, Pela R, Sanguinetti C. Causes of chronic persistent cough in adult patients: the results of a systematic management protocol. Monaldi Arch Chest Disease 1998;510-514.